Key NAFLD/NASH Studies Influencing My Practice Following AASLD 2019

Join Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD, to review the latest practice-changing data from the 2019 meeting in Boston! Hear his take on what you should be doing in your clinic and get answers to your questions in this interactive, CME/CPE-certified Webinar.


  • Program Overview (5 mins)
  • Updating My Practice Following Boston 2019 (25 mins)
    • Summary of the most important studies on NAFLD/NASH
    • Key practice recommendations for the clinic

Question and Answer Session (15 mins)


Date / Time
Event Details


Zobair Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD

Professor and Chairman
Department of Medicine
Inova Fairfax Medical Campus
Falls Church, Virginia

Program Overview
You are invited to attend a CME/CPE-certified Webinar highlighting key take-home messages from the 2019 Liver Meeting.

Goal Statement
The goal of this activity is to improve participants’ competence in translating the most clinically important data from AASLD 2019 into practical management strategies for patients with liver diseases.

Target Audience
This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with liver diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate the results of recent clinical studies of NASH management strategies into clinical practice
  • Implement new data on strategies for diagnosing and managing NASH now and in the future


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Pharmacist Continuing Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-049-L01-P.

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.